Assembly Biosciences' Incubator/Accelerator Round

Assembly Biosciences raised a round of funding on October 08, 2013. Investors include JLabs.

Assembly Biosciences is an infectious disease-focused biopharmaceutical company developing treatments for hepatitis B virus (HBV) infection and C. difficile-associated diarrhea (CDAD). Both programs h…

Articles about Assembly Biosciences' Incubator/Accelerator Round: